April 14, 2014
Drug company Depomed Inc. on Friday said that it has reached settlements with Incepta Pharmaceuticals Ltd. and Zydus Pharmaceuticals USA Inc., two out of the three defendants in ongoing patent infringement litigation over its nerve pain medication Gralise.
May 11, 2012
Drug company Depomed Inc. lodged a patent infringement suit Wednesday in New Jersey in an effort to block plans by Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary to market a generic version of epilepsy medication Gralise.